Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2012536-16-0
| Molecular Weight | 297.35 g/mol |
|---|---|
| Molecular Formula | C14H23N3O4 |
| XLogP3 | -0.9 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 4 |
| Exact Mass | 297.16885622 g/mol |
| Monoisotopic Mass | 297.16885622 g/mol |
| Topological Polar Surface Area | 104 Ų |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 479 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
96
PharmaCompass offers a list of NYX-2925 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right NYX-2925 manufacturer or NYX-2925 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred NYX-2925 manufacturer or NYX-2925 supplier.
PharmaCompass also assists you with knowing the NYX-2925 API Price utilized in the formulation of products. NYX-2925 API Price is not always fixed or binding as the NYX-2925 Price is obtained through a variety of data sources. The NYX-2925 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A NYX-2925 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of NYX-2925, including repackagers and relabelers. The FDA regulates NYX-2925 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. NYX-2925 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A NYX-2925 supplier is an individual or a company that provides NYX-2925 active pharmaceutical ingredient (API) or NYX-2925 finished formulations upon request. The NYX-2925 suppliers may include NYX-2925 API manufacturers, exporters, distributors and traders.
NYX-2925 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of NYX-2925 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right NYX-2925 GMP manufacturer or NYX-2925 GMP API supplier for your needs.
A NYX-2925 CoA (Certificate of Analysis) is a formal document that attests to NYX-2925's compliance with NYX-2925 specifications and serves as a tool for batch-level quality control.
NYX-2925 CoA mostly includes findings from lab analyses of a specific batch. For each NYX-2925 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
NYX-2925 may be tested according to a variety of international standards, such as European Pharmacopoeia (NYX-2925 EP), NYX-2925 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (NYX-2925 USP).
